Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.

Roth T, Stubbs C, Walsh JK.

Sleep. 2005 Mar;28(3):303-7. Erratum in: Sleep. 2006 Apr 1;29(4):417. Dosage error in article text.

PMID:
16173650
3.

The effects of ramelteon in a first-night model of transient insomnia.

Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.

Sleep Med. 2009 Jan;10(1):55-9. doi: 10.1016/j.sleep.2008.04.010. Epub 2008 Aug 8.

PMID:
18691937
4.

Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.

Kryger M, Wang-Weigand S, Zhang J, Roth T.

Sleep Breath. 2008 Aug;12(3):243-50.

PMID:
18060441
5.

Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep.

Markwald RR, Lee-Chiong TL, Burke TM, Snider JA, Wright KP Jr.

Sleep. 2010 Jun;33(6):825-31.

6.

Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.

Mini LJ, Wang-Weigand S, Zhang J.

Am J Geriatr Pharmacother. 2007 Sep;5(3):177-84.

PMID:
17996657
7.

Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.

Richardson G, Wang-Weigand S.

Hum Psychopharmacol. 2009 Mar;24(2):103-11. doi: 10.1002/hup.993.

PMID:
19090503
8.

Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.

Wang-Weigand S, Watissée M, Roth T.

Sleep Med. 2011 Oct;12(9):920-3. doi: 10.1016/j.sleep.2011.06.008. Epub 2011 Sep 16.

PMID:
21925941
9.

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

Roth T, Seiden D, Wang-Weigand S, Zhang J.

Curr Med Res Opin. 2007 May;23(5):1005-14.

PMID:
17519067
10.

[A novel therapeutic drug: ramelteon].

Miyamoto M.

Nihon Rinsho. 2009 Aug;67(8):1595-600. Review. Japanese.

PMID:
19768947
11.

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.

Sleep Med. 2006 Jun;7(4):312-8. Epub 2006 May 18.

PMID:
16709464
12.

Fresh from the pipeline: Ramelteon.

Buysse D, Bate G, Kirkpatrick P.

Nat Rev Drug Discov. 2005 Nov;4(11):881-2. No abstract available.

PMID:
16299918
13.

Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.

Nishiyama K, Shintani Y, Hirai K, Yoshikubo S.

J Pharmacol Exp Ther. 2009 Sep;330(3):855-63. doi: 10.1124/jpet.109.155283. Epub 2009 Jun 25.

14.

Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.

Wang-Weigand S, McCue M, Ogrinc F, Mini L.

Curr Med Res Opin. 2009 May;25(5):1209-13. doi: 10.1185/03007990902858527 .

PMID:
19327100
15.

Ramelteon: profile of a new sleep-promoting medication.

Owen RT.

Drugs Today (Barc). 2006 Apr;42(4):255-63. Review.

PMID:
16703122
16.

Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.

Fisher SP, Davidson K, Kulla A, Sugden D.

J Pineal Res. 2008 Sep;45(2):125-32. doi: 10.1111/j.1600-079X.2008.00565.x. Epub 2008 Feb 19.

PMID:
18298466
17.

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.

Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M.

Neuropharmacology. 2005 Feb;48(2):301-10.

PMID:
15695169
18.

Ramelteon: TAK 375.

[No authors listed]

Drugs R D. 2005;6(3):186-8. Review.

PMID:
15869323
19.

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

Erman M, Seiden D, Zammit G, Sainati S, Zhang J.

Sleep Med. 2006 Jan;7(1):17-24. Epub 2005 Nov 23.

PMID:
16309958
20.

Ramelteon: a review of its use in insomnia.

Simpson D, Curran MP.

Drugs. 2008;68(13):1901-19. Review.

PMID:
18729542
Items per page

Supplemental Content

Write to the Help Desk